Verastem | VSTM - Ordinary Share Capital


Verastem reported $4K in Ordinary Share Capital for its fiscal quarter ending in September of 2024.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Alaunos Therapeutics USD 2.21M 2.2M Sep/2025
AstraZeneca USD 1.55B 206K Dec/2025
Curis USD 59K 934K Sep/2023
Cytokinetics USD 122.26M 145K Dec/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
Laboratory Of America USD 82.2M 700K Dec/2025
Novartis USD 1.94B 23.4M Jun/2025
Pfizer USD 5.69B 1000K Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
TG Therapeutics USD 155.21M 2.81M Sep/2025
Verastem USD 4K 1000 Sep/2024